Overlooked.....

Most recent posts on this forum have focussed on the Korean Deal and I believe we have become myopic in our views of the company.
The occasional post, rightly, points out that we have many "irons in the fire." GIMP, Cannepil, Derma range, Australian License etc. There is one that I think we may have overlooked.
In the half yearly the company reported on the relationship with RMIT and in particular the research into how medicinal marijuana can impact cancer, causes and symptoms.
There are a few words that are bobbing around the investment world at the moment that make people sit up and take notice. Lithium, Microgrids, Infant formula, Blockchain, MM and cancer (relief or cure).
I have not seen too many posts on this topic, hence I think we may be dismissing the value of the RMIT relationship. Just imagine the impact on our share price if we had an announcement with "MM" and "Cancer" in the title followed by the first line "MGC and RMIT are pleased to announce that....."